BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27933487)

  • 1. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients.
    Olmos-Jiménez R; Díaz-Carrasco MS; Galera-Miñarro A; Pascual-Gazquez JF; Espuny-Miró A
    Int J Clin Pharm; 2017 Feb; 39(1):126-132. PubMed ID: 27933487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological adult patients.
    Olmos-Jiménez R; Díaz-Carrasco MS; Cabañas-Perianes V; Valderrey-Pulido M; Espuny-Miró A
    Farm Hosp; 2017 Sep; 41(5):611-617. PubMed ID: 28847250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
    Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
    Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
    Bassan R; Masciulli A; Intermesoli T; Audisio E; Rossi G; Pogliani EM; Cassibba V; Mattei D; Romani C; Cortelezzi A; Corti C; Scattolin AM; Spinelli O; Tosi M; Parolini M; Marmont F; Borlenghi E; Fumagalli M; Cortelazzo S; Gallamini A; Marfisi RM; Oldani E; Rambaldi A
    Haematologica; 2015 Jun; 100(6):786-93. PubMed ID: 25749825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of inadvertent administration of overdose of intrathecal Cytarabine in a pediatric patient.
    Al Omar S; Amayiri N; Madanat F
    J Oncol Pharm Pract; 2015 Oct; 21(5):384-7. PubMed ID: 24781453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
    Holdsworth MT; Raisch DW; Winter SS; Chavez CM
    Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Pullen J; Boyett J; Shuster J; Crist W; Land V; Frankel L; Iyer R; Backstrom L; van Eys J; Harris M
    J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
    Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids.
    Tzachanis D; Haider M; Papazisis G
    Am J Ther; 2016; 23(3):e937-40. PubMed ID: 24987945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature.
    Alsdorf WH; Schmitz M; Schieferdecker A; Dierlamm J; Bokemeyer C; Binder M
    J Oncol Pharm Pract; 2016 Jun; 22(3):523-7. PubMed ID: 25655468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
    Bleyer A; Choi M; Wang SJ; Fuller CD; Raney RB
    Pediatr Blood Cancer; 2009 Dec; 53(7):1205-10. PubMed ID: 19821538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
    Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
    Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
    Kwong YL; Yeung DY; Chan JC
    Ann Hematol; 2009 Mar; 88(3):193-201. PubMed ID: 19050889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
    J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy vs intrathecal chemotherapy for CNS prophylaxis in childhood ALL.
    Steinherz PG
    Oncology (Williston Park); 1989 Sep; 3(9):47-53; discussion 58-60. PubMed ID: 2701698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal chemotherapy-associated cerebral vasospasm in children with hematologic malignancies.
    Sun LR; Ziai W; Brown P; Torriente AG; Cooper S; Gottesman RF; Felling RJ
    Pediatr Res; 2021 Mar; 89(4):858-862. PubMed ID: 32544924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.